www.statnews.com Despite Novo drug’s failure, cardiologists say they will still pursue anti-inflammatories “These results, the fact that they're negative, does not invalidate that inflammation plays a very important role in cardiovascular disease." 
www.statnews.com Zolgensma tumor cases show risks of a common gene therapy tool New cases show AAV gene therapies like Zolgensma carry tumor risks, raising key concerns for SMA patients and gene therapy researchers in general. 
www.statnews.com Revolution's pancreatic cancer drug has stunning commercial debut Rasonque, Revolution Medicines' new pancreatic cancer drug, is off to one of the best oncology drug launches in history. 
www.statnews.com In China, a flood of controversial clinical trials slows to a trickle Following patient deaths, China restricts investigator-initiated biotech trials, leaving rare disease families and US investors facing an uncertain future. www.statnews.com In China, a flood of controversial clinical trials slows to a trickle Following patient deaths, China restricts investigator-initiated biotech trials, leaving rare disease families and US investors facing an uncertain future. 